A new parliamentary standing committee report sheds light on the government’s ‘dilly-dallying and procrastination’ over serious irregularities in the approval of various drugs, many of them banned in countries like the US.
The Bachelor of Science (Community Health) course has been dealt a severe blow with a parliamentary standing committee recommending the government not to go ahead with it. The course which has surfaced under different names from
In a move to discourage the rampant frequency with which untested drugs are released in India, all pharmaceutical companies that conduct clinical trials will have to register internal ethics committees. The latest gazette
14 years – that’s how long Deanxit, anti-depressant marketed by a Danish company was sold in this country until its safety and efficacy was questioned. The drug in question is an antidepressant which is mostly marketed in
India’s healthcare system is heavily skewed towards tertiary services which mean that primary healthcare gets neglected. General practitioners and friendly neighborhood family doctors are becoming an extinct species with
The Drug Controller General of India (DCGI) has asked all pharmaceutical companies to submit safety details of their new drugs every six months after their launch, failing which their licenses would be cancelled. They’re
Clinical drug trials killed 1144 people in the last two years, the government said today. Earlier we had reported how from 2008-2011 clinical trials caused over 2000 deaths however only 22 received compensation.
Of the 1144
The Drugs Controller General of India (DCGI), after issuing guidelines on registration of ethics committees and inspection of trial sites, has now issued directions to the committees to keep a vigil on drug trials.
“The
Want to be India’s top drug inspector (DCGI)? All you need is a grad degree in pharmacy or a degree in medicine with PG in clinical pharmacology or microbiology (MD) along with five years' experience. India has the third
After the parliamentary standing committee pointed out huge irregularities in the functioning of the Central Drugs Standards Control Organisation (CDSCO), Health Minister Ghulam Nabi Azad announced that a three-member committee
The Medical Council of India has vowed to take stern action against rogue doctors who had recommended certain drugs to the CDSCO, recommendations which were written by drug companies themselves. Yesterday the nexus between drug